Amine precursors in neurologic disorders and the psychoses.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D003342:Corpus Striatum / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D007980:Levodopa / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D009069:Movement Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D009410:Nerve Degeneration; D010300:Parkinson Disease / Q000134:cerebrospinal fluid / Q000378:metabolism; D011605:Psychoses, Substance-Induced / Q000209:etiology; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000378:metabolism
D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D000109:Acetylcholine; D004298:Dopamine; D006719:Homovanillic Acid